Roche Acquires Diabetes Biotech Marcadia
This article was originally published in The Pink Sheet Daily
Executive Summary
In the wake of its taspoglutide disappointment, Roche is acquiring privately-owned U.S. metabolic treatment maker Marcadia Biotech for an undisclosed sum.